Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Physiological and pharmacological characterization of the N1303K mutant CFTR.

Physiological and pharmacological characterization of the N1303K mutant CFTR.

Resource Type

CF Research News

Authors

DeStefano S, Gees M, Hwang TC

References

J Cyst Fibros. 2018 Jun 7. pii: S1569-1993(18)30593-9. doi: 10.1016/j.jcf.2018.05.011. 

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

GLPG1837 [3]
Gating; N1303K [4]
VX-661 [5]
VX-770 [6]
VX-809 [7]

Date

Thursday, June 7, 2018

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [8]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/physiological-and-pharmacological-characterization-n1303k-mutant

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-18-00121R1_FINAL_Hwang_090618.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=Physiological%20and%20pharmacological%20characterization%20of%20the%20N1303K%20Mutant%20CFTR [3] https://www.ecfs.eu/research-article-keywords/glpg1837 [4] https://www.ecfs.eu/research-article-keywords/gating-n1303k [5] https://www.ecfs.eu/research-article-keywords/vx-661 [6] https://www.ecfs.eu/research-article-keywords/vx-770 [7] https://www.ecfs.eu/research-article-keywords/vx-809 [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines